Alpha 2.0
Login Register
» Articles » PMID: 12682649

FGF-2 Expression and Its Action in Human Leukemia and Lymphoma Cell Lines

Overview
Journal Leukemia
Specialties Hematology
Oncology
Date 2003 Apr 12
PMID 12682649
Citations 8
Authors
P Krejci
J Faitova
H Laurell
A Hampl
P Dvorak
Affiliations
Soon will be listed here.
Citing Articles

Exploiting the fibroblast growth factor receptor-1 vulnerability to therapeutically restrict the MYC-EZH2-CDKN1C axis-driven proliferation in Mantle cell lymphoma.

Sircar A, Singh S, Xu-Monette Z, Coyle K, Hilton L, Chavdoula E Leukemia. 2023; 37(10):2094-2106.

PMID: 37598282 PMC: 10539170. DOI: 10.1038/s41375-023-02006-8.

Blockade of FGF2/FGFR2 partially overcomes bone marrow mesenchymal stromal cells mediated progression of T-cell acute lymphoblastic leukaemia.

Tian C, Li Y, Wang L, Si J, Zheng Y, Kang J Cell Death Dis. 2022; 13(11):922.

PMID: 36333298 PMC: 9636388. DOI: 10.1038/s41419-022-05377-5.

Periostin gene expression in neu-positive breast cancer cells is regulated by a FGFR signaling cross talk with TGFβ/PI3K/AKT pathways.

Labreche C, Cook D, Abou-Hamad J, Pascoal J, Pryce B, Al-Zahrani K Breast Cancer Res. 2021; 23(1):107.

PMID: 34809697 PMC: 8607680. DOI: 10.1186/s13058-021-01487-8.

Identification of Sex-Specific Transcriptome Responses to Polychlorinated Biphenyls (PCBs).

Espin-Perez A, Hebels D, Kiviranta H, Rantakokko P, Georgiadis P, Botsivali M Sci Rep. 2019; 9(1):746.

PMID: 30679748 PMC: 6346099. DOI: 10.1038/s41598-018-37449-y.

Adipose stem cell crosstalk with chemo-residual breast cancer cells: implications for tumor recurrence.

Lyes M, Payne S, Ferrell P, Pizzo S, Hollenbeck S, Bachelder R Breast Cancer Res Treat. 2018; 174(2):413-422.

PMID: 30594967 PMC: 6422973. DOI: 10.1007/s10549-018-05103-w.